Market
Primary focus of McKinsey's PR strategy in 2025 following settlement?
2
Resolution / Starting Odds
Corporate responsibility initiatives • 25%
Rebranding efforts • 25%
Legal compliance and transparency • 25%
Client engagement and trust-building • 25%
Press releases and corporate communications from McKinsey
Story
McKinsey to Pay $650 Million to Settle DOJ Opioid Probe; Ex-Partner Pleads Guilty
Dec 13, 2024, 03:19 PM
McKinsey & Company has agreed to pay $650 million to settle U.S. Department of Justice criminal and civil investigations into its advisory work with opioid manufacturers, including Purdue Pharma, maker of OxyContin. The consulting firm accepted responsibility for its role in advising opioid producers on how to boost sales, including 'turbocharging' OxyContin sales, which prosecutors said contributed to the opioid epidemic. McKinsey entered into a five-year deferred prosecution agreement to resolve criminal charges, including conspiring with Purdue Pharma and others to aid and abet misbranding of prescription drugs. A former senior partner will plead guilty to obstruction of justice.
View original story
Similar markets
Significantly Improved • 25%
Worsened • 25%
No Change • 25%
Slightly Improved • 25%
No significant actions • 25%
File for bankruptcy again • 25%
Rebrand or restructure • 25%
Reach new settlements with other firms • 25%
Decrease • 25%
Significant Increase • 25%
Moderate Increase • 25%
No Change • 25%
Minor impact on business operations • 25%
Improvement in business operations • 25%
No impact on business operations • 25%
Significant decline in business operations • 25%
Moderately negative • 25%
Positive • 25%
Significantly negative • 25%
Neutral • 25%
No • 50%
Yes • 50%
Increase • 25%
Decrease • 25%
No significant change • 25%
Uncertain/Other • 25%